small molecule

VALRELEASE

DIAZEPAM

Loss of exclusivityloss of exclusivity
CompanyHOFFMANN LA ROCHE INC

Drug detail

Brand nameVALRELEASE
Active ingredientDIAZEPAM
Strength15MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

VALRELEASE patent cliff — loss of exclusivity — | CliffBio